Lenvima 10mg

What is Lenvima 10mg?

Lenvima 10mg is lenvatinib, a kinase inhibitor cancer medicine, sold in India under the Lenvima brand name by Eisai Pharmaceuticals India Pvt. Ltd. Each hard capsule contains lenvatinib 10 mg, as lenvatinib mesylate.

What it is used for

According to the US FDA label for Lenvima (DailyMed), lenvatinib is used for differentiated thyroid cancer that no longer responds to radioactive iodine, advanced kidney cancer in combination with other medicines, first line treatment of unresectable liver cancer, and, together with pembrolizumab, advanced endometrial cancer that is mismatch repair proficient (pMMR) or not MSI-H, after earlier treatment, in patients who cannot have curative surgery or radiation. Your doctor decides whether it suits you.

Packs and price

Lenvima 10mg comes in packs of 10, 20 and 30 capsules. The lowest price works out at about $38.67 per capsule on the 30 capsule pack, as of October 2026; the pack selector shows the current price. Shipping is $25 on orders under $149 and free from $149.

Prescription status

Lenvatinib is a prescription medicine in the US, UK, Australia and Canada. Lenvima 10mg itself is an Indian market pack and is not approved by the FDA, MHRA, TGA or Health Canada. The FDA says that importing unapproved medicines for personal use is illegal in most circumstances, so check the rules where you live.

Before you order

Read the patient leaflet that comes with the pack. Tell your doctor or pharmacist about any other medicines you take and any health conditions you have. Get urgent medical help if you notice signs of an allergic reaction, such as swelling of the face, lips, tongue or throat, trouble breathing, or a widespread rash.

Delivery

Orders usually arrive in 7 to 14 business days in plain packaging, with a tracking number.